US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL
Patent 12065478 was granted and assigned to Hoffmann-La Roche Limited on August, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 9, 2020
0
Date of Patent
August 20, 2024
0
Patent Applicant
Patent Application Number
17066711
0
Patent Citations
•••
Patent Inventor Names
Christina Claus
0
Teemu Tapani Junttila
0
Christian Klein
0
Claudia Ferrara Koller
0
Pablo Umana
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.